Advances in therapeutic protein production and delivery

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 2, Issue 2, 2010, Pages 1-5

  Nayak, Amit Kumar ^a  

^a SEEMANTA INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Protein delivery; Protein production; Proteins; Therapeutic proteins

Indexed keywords

ALPHA INTERFERON; APROTININ; BETA INTERFERON; BLOOD CLOTTING FACTOR 8; ENKEPHALIN; ERYTHROPOIETIN; GAMMA INTERFERON; GLUCOSYLCERAMIDASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; GROWTH HORMONE; HEPATITIS B VACCINE; HIRUDIN; INSULIN; INTERLEUKIN 2; LACTOFERRIN; LIPOSOME; PROTEIN C; SERUM ALBUMIN; STREPTOKINASE; VIRUS VECTOR;

ANIMAL CELL CULTURE; BIOTECHNOLOGICAL PRODUCTION; CONTROLLED RELEASE FORMULATION; CULTURE TECHNIQUE; DRUG DELIVERY SYSTEM; DRUG IMPURITY; DRUG SAFETY; HUMAN; HYBRIDOMA CELL CULTURE; NONHUMAN; PHARMACEUTICAL ENGINEERING; PROTEIN ENGINEERING; PROTEIN PURIFICATION; REVIEW; TRANSGENIC ANIMAL; TRANSGENIC PLANT; TRANSGENICS;

EID: 77953397706     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Hermeling S, Crommalin DJA. Structure-Immunogenicity relationship of therapeutic proteins. Pharma Res 2004; 21(6): 897-903.
2. Regan L, Jackson SE. Engineering and design: Protein design, theory and practice, editorial overview. Curr Opin Str Biol 2003; 13: 479-81.
3. st ed. Vallabh Prakashan, Delhi; 2006. p. 503-70.
4. Vithayalingam S, Ahamed SU. Current status of controlled drug delivery - Technology overviews. Drug Delivery Companies Report; Spring/Summer 2005: 34-38.
5. Mrsny RJ. Strategies for targeting protein therapeutics to selected tissues and cells. Expert Opin Biol Ther 2004; 4(1): 65-73.
6. Micheal W. Bioprocessing: Expression of antibody in Aspergillus niger. Daily Biotech Updates 2002; 22(21): 1-3.
7. Lee SY, Kim HU, Park JH, Park JM, Kim TY. Metabolic engineering of microorganisms: general strategies and drug production. Drug Discov Today 2009; 14(1/2): 78-88.
8. Menzella HG, Reeves CD. Combinatorial biosynthesis for drug development. Curr Opin Microbiol 2007; 10: 238-45.
9. Jonasson P, Liljeqvest S, Nygren P, Stefan S. Genetic design for facilitated production and recovery of recombinant proteins in Escherichia coli. Biotechnol Appl Biochem 2002, 35: 91-105.
10. Kelley BD. Biochemical engineering: Bioprocessing of therapeutic proteins. Curr Opin Biotech 2001; 12: 173-74.
11. Harare AA, Dange AS, Shetty YT. Therapeutic protein production and protein delivery: an overview. Indian J Pharm Edu Res 2008; 42(2): 104-12.
12. Clark J, Whitelaw B. A future for transgenic live stock. Nat Rev Genet 2003; 4(10): 825-33.
13. Houdebine LM. Animal transgenesis: Recent data perspectives. Biochemie 2002; 84: 1137-41.
14. Suslow TV, Thomas BR, Bradford KJ. Biotechnology provides new tools for planting. Oakland: University of California, Division of Agriculture and Natural Resources, Publication 8043. http://anrcatalog.ucdavis.edu.
15. Rybicki EP. Plant-produced vaccines: promise and reality. Drug Discov Today 2009; 14(1/2): 16-25.
16. Lis H, Sharon N. Protein glycosylation: Structure and functional aspects. Curr J Biochem 1993; 218(1): 27.
17. Berta A. The expression of nopaline synthetase human growth hormone chemiric gene in transformed tobacco and sunflower callus culture. Plant Mol Biol 1986; 6: 347-57.
18. Daniell H, Streatfield SJ, Wycoff K. Medical molecular farming: Production of antibiotics, biopharmaceuticals, and edible vaccines in plants. Trends in Plant Sci 2001; 6: 219-26.
19. Protein purification handbook. Amersham Pharmacia Biotech. Online. www.Biochem.uiowa.edu/database/protein_purification_handbook.
20. Wang W. Instability, stabilization and formulation of liquid protein pharmaceuticals. Int J Pharm 1999; 185: 129-58.
21. Almeida AJ, Sonto E. Solid lipid nanoparticles as drug delivery systems for peptides and proteins. Adv Drug Deliv Rev 2007; 59: 478-90.
22. Crommelin D, van Winden E, Mekking A. Delivery of therapeutic proteins, In: Aulton ME, ed. Pharmaceutics: The Science of Dosage Forms Design, Churchill Living stone, Edinburgh. 2001.p. 544-53.
23. Crommelin D, Storm G, Verrijk R, de Leede I, Jiskoot W, Hennink WE. Shifting paradigms: biopharmaceuticals versus low molecular weight drug. Int J Pharm 2003; 266: 3-16.
24. Pettit DK, Gombotz WR. The development of site-specific drug delivery systems for protein and peptide biopharmaceuticals. Trends Biotechnol 1998; 16: 343-49.
25. Ghilzai NMK, Desai A. Facing the challenges of transmucosal absorption-buccal, nasal and rectal routes. Pharma Tech 2004. Business Briefing World Market Series, London 2004; 104-06.
26. Banga AK. Drug delivery today. Pharma Tech. 2002. Business Briefing World Market Series, London. 2002; 150-54.
27. Ugwoke MI, Agu RU, Verbeke N, Kinget R. Nasal Mucoadhesive drug delivery: background, applications, trends and future perspectives. Adv Drug Deliv Rev 2005; 57: 1640-65.
28. Myles ME, Neumman DM, Hill JR. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis. Adv Drug Deliv Rev 2005; 57: 2063-79.
29. Smart JD. Buccal drug delivery. Expert Opin Drug Deliv 2005; 2: 507-17.
30. Agu RU, Ugwoke MI, Armand M, Kinget R, Verbeke N. The lung as a route for systemic delivery of therapeutic proteins and peptides. Respir Res 2001; 2: 198-209.
31. Schuctz YB, Naik A, Guy RH, Kalia YN. Emerging strategies for transdermal delivery of peptide and protein drugs. Expert Opin Drug Deliv 2005; 2: 533-48.
32. Mackay M, Philips J, Hastewell J. Peptide drug delivery. Colonic and rectal absorption. Adv Drug Deliv Rev 1997; 28: 253-73.
33. Hussain A, Ahsan F. The vagina as a route of systemic drug delivery. J Control Release 2005; 103: 301-13.
34. Jie F, Jenifer F, Gric K, Justin H. New polymeric carriers for controlled drug delivery following inhalation or injection. Biomaterials 2002; 23: 4423-33.
35. Han HK. Targeted prodrug design to optimize drug delivery. AAPS PharmSci Tech 2002; 2(1): article 6.
36. Reineke TM, Grinstaff MW. Designer material for nucleic acid delivery. MRS Bulletin 2005; 30: 635-39.